Diffusion tensor imaging (DTI), magnetization transfer imaging (MT) and automated brain volumetry were used to summarize brain involvement in human immunodeficiency virus (HIV) infection. A multiparametric neuroimaging protocol was implemented at 1.5 T in 10 HIV + and 24 controls. Various summary parameters were calculated based on DTI, MT, and automated brain volumetry. The magnitude of the difference, as well as the between-group discrimination, was determined for each measure. Bivariate correlations were computed and redundancy among imaging parameters was examined by principal factor analysis. Significant or nearly significant differences were found for most measures. Large Cohen's d effect sizes were indicated for mean diffusivity (MD), fractional anisotropy (FA), magnetization transfer ratio (MTR) and gray matter volume fraction (GM). Between-group discrimination was excellent for FA and MTR and acceptable for MD. Correlations among all imaging parameters could be explained by three factors, possibly reflecting general atrophy, neuronal loss, and alterations. This investigation supports the utility of summary measurements of brain involvement in HIV infection. The findings also support assumptions concerning the enhanced sensitivity of DTI and MT to atrophic as well as alterations in the brain. These findings are broadly generalizable to brain imaging studies of physiological and pathological processes.
Introduction
Individuals infected with the human immunodeficiency virus (HIV) are at considerable risk of brain injury and cognitive deterioration, and these neurological complications have a significant impact on survival (Sevigny et al., 2007) . Ongoing injury to the brain, however, may be clinically silent for indefinite periods, and damage may be irreversible by the time symptoms present. Quantitative imaging strategies such as diffusion tensor imaging (DTI), magnetization transfer imaging (MT) and brain segmentation have been used in efforts to clarify the nature of the injury to the brain and to determine factors associated with increased risk. For example, aggregate microstructural brain alterations can be derived with DTI, which exploits the random translational movements of water molecules to probe tissue at a level approximating cellular dimensions (Basser and Pierpaoli, 1996) . DTI measurements differ in human immunodeficiency virus positive (HIV+) and control subjects (Filippi et al., 2001; Pomara et al., 2001; Ragin et al., 2004 Ragin et al., , 2005 Thurnher et al., 2005; Wu et al., 2006; Pfefferbaum et al., 2007 Pfefferbaum et al., , 2009 Stebbins et al., 2007; Chen et al., 2009; Gongvatana et al., 2009) , and these measures correlate with cognitive deficits (Ragin et al., 2004 (Ragin et al., , 2005 Wu et al., 2006; Gongvatana et al., 2009) . MT imaging has been used to quantify pathologic changes in macromolecules due to tissue injury and destruction (van Buchem et al., 1999) . MT measures differ in HIV+ from control subjects and correlate with cognitive impairment (Ge et al., 2003; Ragin et al., 2004; Wu et al., 2008) . Automated brain segmentation algorithms can be used to derive volume fractions of gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) within the individual cranial cavity, as well as parenchymal and ventricular volumes relative to normative population brain size (Zhang et al., 2001; Smith et al., 2002; Smith, 2004) . The volumetric measurements derived with these strategies have been determined to be robust and accurate in simulation studies against known tissue volumes (Zhang et al., 2001; Smith et al., 2002; Smith, 2004) . Volumetric strategies have been used to investigate brain injury in HIV infection (e.g., Thompson et al., 2005 Thompson et al., , 2006 . The summary measurements that can be derived with quantitative imaging strategies represent promising tools for identifying factors 
